XENPOZYME
Live / Registered — Registered (as of 08 Nov 2022)
What this means for you
Registered since 08 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90407808
- Registration number
- 6896175
- Mark type
- Design + words
- Filed
- 23 Dec 2020
- Published for opposition
- 27 Jul 2021
- Registered
- 08 Nov 2022
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 08 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Sept 2022 — USE AMENDMENT FILED
- 06 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 02 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2022 — SOU EXTENSION 2 GRANTED
- 29 Jul 2022 — SOU EXTENSION 2 FILED
- 29 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2022 — SOU EXTENSION 1 GRANTED
- 09 Feb 2022 — SOU EXTENSION 1 FILED